BSE filing, NSE: ADANIENT. Summary written from the filing by ALFA Finder's alert engine.
Adani Enterprises Ltd: key numbers
- Share price
- ₹2,479.80
- Market cap
- ₹3,35,619 Cr
- Revenue (annual)
- ₹1,00,469 Cr
- Net profit (annual)
- ₹9,339 Cr
- P/E (TTM)
- 58.5×Sector 36.4×
- Promoter holding
- 71.97%-2.87% QoQ
- FII holding
- 10.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Adani Enterprises Ltd
All →Adani Enterprises Earnings Call Transcript: Key Takeaways
Adani Enterprises delivered record half-yearly EBITDA, driven by a significant ramp-up in the newly commissioned copper business and airport infrastructure.
Adani Enterprises Results Update
AEL reported H1 FY27 EBITDA of Rs. 11,958 cr, up 56% YoY. ANIL hit 10 GW solar capacity; AdaniConnex signed a 240 MW data center order.
Adani Enterprises Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹38,023 cr (+74%) and EBITDA ₹6,316 cr (+62%). H1 EBITDA is a record ₹11,958 cr (+56%), driven by copper ramp-up and airports.
Adani Enterprises Board Meeting Correction
Adani Enterprises corrected the date on its Board Meeting outcome cover letter from September 28 to October 28, 2026. No board decisions or financial figures were altered.
Adani Enterprises Q2 FY27 Results: Net Profit ₹1,221 Cr, Down 64.2% YoY
Adani Enterprises Ltd reported revenue from operations of ₹37,216 Cr (+75.1% YoY) and net profit of ₹1,221 Cr (-64.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,221 Cr · -64.2% YoY
Adani Enterprises Annual General Meeting
Adani Enterprises shareholders approved Anju Abrol's appointment as Independent Director via postal ballot, with 99.95% votes in favour. Scrutinizer's report and voting results were filed.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.